{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:30:21Z","timestamp":1790008221998,"version":"4.0.1"},"reference-count":40,"publisher":"BMJ","issue":"6","funder":[{"DOI":"10.13039\/501100001822","name":"Austrian Academy of Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001822","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016285","name":"Special Programme for Research and Training in Tropical Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016285","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,5,4]]},"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Lack of investments in drug development, lack of standardisation of clinical trials and the complexity of disease presentations contribute to the current lack of effective, safe and adapted treatments for cutaneous leishmaniasis (CL). One aspect concerns outcomes affecting patients\u2019 quality of life (QoL): these are hardly assessed in trials, despite potential functional and\/or aesthetic impairment caused by CL, which typically affects disadvantaged and vulnerable people living in rural areas. Here, we describe the approach used to bring perspectives of patients with CL into designing and assessing treatments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This international qualitative study uses interviews with patients to explore their experiences with CL to (1) elicit outcomes and eligibility criteria for clinical trials important to them and (2) to better understand their needs and views about the disease and their requirements and expectations from treatment. Here, we describe the set-up of this collaborative study and the protocol. Data collection is ongoing.<\/jats:p>\n                  <jats:p>The protocol includes study design, preparation, conduct and analysis of individual interviews with approximately 80 patients in seven countries (Burkina Faso, Brazil, two sites in Colombia, Iran, Morocco, Peru and Tunisia) where CL is prevalent. Principal investigators and sites were selected through an open call, and two workshops were organised for protocol development and training in conduct and analysis of qualitative health research. Patient recruitment aims at covering a maximum variation of experiences. Transcripts will be analysed to identify outcomes and eligibility criteria as well as further topics that are expected to emerge from the interviews, such as direct and indirect costs related to CL, its psychological impact, preferred modes of drug administration and traditional treatments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The study received ethical approval by the responsible committees of each of the participating institutions. Findings will be disseminated through publication in peer-reviewed journals, scientific meetings and to participants and their communities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-021372","type":"journal-article","created":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T01:55:53Z","timestamp":1529114153000},"page":"e021372","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["An international qualitative study exploring patients\u2019 experiences of cutaneous leishmaniasis: study set-up and protocol"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5252-9676","authenticated-orcid":false,"given":"Astrid Christine","family":"Erber","sequence":"first","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Arana","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3553-5430","authenticated-orcid":false,"given":"Issam","family":"Bennis","sequence":"additional","affiliation":[{"name":"National School of Public Health, Rabat, Morocco"},{"name":"Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afif","family":"Ben Salah","sequence":"additional","affiliation":[{"name":"Institut Pasteur de Tunis, Tunis, Tunisia"},{"name":"Department of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University (AGU), Manama, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aicha","family":"Boukthir","sequence":"additional","affiliation":[{"name":"Institut Pasteur de Tunis, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-2919","authenticated-orcid":false,"given":"Maria del Mar","family":"Castro Noriega","sequence":"additional","affiliation":[{"name":"Centro Internacional de Entrenamiento de Investigaciones M\u00e9dicas (CIDEIM), Cali, Colombia"},{"name":"EDCTP\/TDR Fellow, European Vaccine Initiative (EVI), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoudou","family":"Ciss\u00e9","sequence":"additional","affiliation":[{"name":"Centre MURAZ, Bobo-Dioulasso, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00e1ucia Fernandes","family":"Cota","sequence":"additional","affiliation":[{"name":"Centro de Pesquisa Ren\u00e9 Rachou (CPqRR), Funda\u00e7\u00e3o Oswaldo Cruz (FIOCRUZ), Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Handjani","sequence":"additional","affiliation":[{"name":"Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairie Guizaw","family":"Kebede","sequence":"additional","affiliation":[{"name":"Ayder Referral Hospital, College of Health Sciences, Mekelle University, Mekelle, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudie","family":"Lang","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"L\u00f3pez Carvajal","sequence":"additional","affiliation":[{"name":"Programa de Estudio y Control de Enfermedades Tropicales (PECET), Universidad de Antioquia, Medell\u00edn, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Marsh","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila","family":"Martinez Medina","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru"},{"name":"Departamento de Enfermedades Infecciosas, Dermatol\u00f3gicas y Tropicales, Hospital Cayetano Heredia, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Plugge","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Olliaro","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Special Programme for Research & Training in Tropical Diseases (WHO\/TDR), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"key":"2025101814563271000_8.6.e021372.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"2025101814563271000_8.6.e021372.2","unstructured":"World Health Organization. Leishmaniasis fact sheet. 2018. http:\/\/www.who.int\/mediacentre\/factsheets\/fs375\/en\/ (accessed 18 Apr 2018)."},{"key":"2025101814563271000_8.6.e021372.3","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez U , Pinart M , Reveiz L , et al . Interventions for old world cutaneous leishmaniasis. Cochrane database of systematic reviews. 30: John Wiley & Sons, Ltd, 2008. (accessed 22 Apr 2014).doi:10.1002\/14651858.CD005067.pub3","DOI":"10.1002\/14651858.CD005067.pub3"},{"key":"2025101814563271000_8.6.e021372.4","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez U , Pinart M , Rengifo-Pardo M , et al . Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane database of systematic reviews. 180: John Wiley & Sons, Ltd, 2009. (accessed 22 Apr 2014).doi:10.1002\/14651858.CD004834.pub2","DOI":"10.1002\/14651858.CD004834.pub2"},{"key":"2025101814563271000_8.6.e021372.5","doi-asserted-by":"publisher","DOI":"10.1086\/655134"},{"key":"2025101814563271000_8.6.e021372.6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0132-1"},{"key":"2025101814563271000_8.6.e021372.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061843"},{"key":"2025101814563271000_8.6.e021372.8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/tmi.13048","article-title":"Eligibility criteria and outcome measures adopted in clinical trials of treatments of cutaneous leishmaniasis: systematic literature review covering the period 1991-2015","volume":"23","author":"L\u00f3pez-Carvajal","year":"2018","journal-title":"Trop Med Int Health"},{"key":"2025101814563271000_8.6.e021372.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002130"},{"key":"2025101814563271000_8.6.e021372.10","doi-asserted-by":"crossref","first-page":"e0006141","DOI":"10.1371\/journal.pntd.0006141","article-title":"Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation","volume":"12","author":"Olliaro","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2025101814563271000_8.6.e021372.11","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-89"},{"key":"2025101814563271000_8.6.e021372.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.12"},{"key":"2025101814563271000_8.6.e021372.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.11.013"},{"key":"2025101814563271000_8.6.e021372.14","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-15-247","article-title":"Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a \u2019core outcome set'","volume":"15","author":"Prinsen","year":"2014","journal-title":"Trials"},{"key":"2025101814563271000_8.6.e021372.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000393"},{"key":"2025101814563271000_8.6.e021372.16","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-8-38","article-title":"OMERACT: an international initiative to improve outcome measurement in rheumatology","volume":"8","author":"Tugwell","year":"2007","journal-title":"Trials"},{"key":"2025101814563271000_8.6.e021372.17","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"key":"2025101814563271000_8.6.e021372.18","doi-asserted-by":"publisher","DOI":"10.1258\/jhsrp.2011.011131"},{"key":"2025101814563271000_8.6.e021372.19","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","volume":"8","author":"Clarke","year":"2007","journal-title":"Trials"},{"key":"2025101814563271000_8.6.e021372.20","unstructured":"COMET. Home :: Core Outcome Measures in Effectiveness Trials Initiative (COMET). 2017 http:\/\/www.comet-initiative.org\/ (accessed 15 Nov 2017)."},{"key":"2025101814563271000_8.6.e021372.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pctr.0010009"},{"key":"2025101814563271000_8.6.e021372.22","unstructured":"WHO\/TDR. Call for expression of interest. 2015 http:\/\/www.who.int\/tdr\/grants\/CL_Call_for_Expression_of_Interest.pdf?ua=1 (accessed 18 Jul 2017)."},{"key":"2025101814563271000_8.6.e021372.23","unstructured":"Creswell JW . Research design: qualitative, quantitative, and mixed methods approaches. 4th ed: SAGE Publications, 2013."},{"key":"2025101814563271000_8.6.e021372.24","unstructured":"Creswell JW , Plano Clark VL . Designing and conducting mixed methods research. 2nd ed: SAGE Publications, 2011."},{"key":"2025101814563271000_8.6.e021372.25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3102\/0013189X021006013","article-title":"Notes on pragmatism and scientific realism","volume":"21","author":"Cherryholmes","year":"1992","journal-title":"Educ Res"},{"key":"2025101814563271000_8.6.e021372.26","unstructured":"Patton MQ . Qualitative evaluation and research methods: SAGE Publications, 1990."},{"key":"2025101814563271000_8.6.e021372.27","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2025101814563271000_8.6.e021372.28","unstructured":"Green J , Thorogood N . Qualitative methods for health research. 3rd ed: SAGE Publications, 2014."},{"key":"2025101814563271000_8.6.e021372.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7227.114"},{"key":"2025101814563271000_8.6.e021372.30","doi-asserted-by":"crossref","unstructured":"Gobo G . Sampling, representativeness and generalizability. In: Seale C , Gobo G , Gubrium JF , eds. Qualitative research practice: SAGE Publications, 2004:405\u201327.","DOI":"10.4135\/9781848608191.d34"},{"key":"2025101814563271000_8.6.e021372.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.6997.109"},{"key":"2025101814563271000_8.6.e021372.32","unstructured":"Neuman WL . Social research methods: qualitative and quantitative approaches. 7th ed: Pearson, 2013."},{"key":"2025101814563271000_8.6.e021372.33","unstructured":"Bowling A . \u00a0Research methods in health: investigating health and health services: McGraw-Hill International, 2009."},{"key":"2025101814563271000_8.6.e021372.34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-117"},{"key":"2025101814563271000_8.6.e021372.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2929.2006.02467.x"},{"key":"2025101814563271000_8.6.e021372.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"2025101814563271000_8.6.e021372.37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12889-018-5260-9","article-title":"Psychosocial burden of localised cutaneous Leishmaniasis: a scoping review","volume":"18","author":"Bennis","year":"2018","journal-title":"BMC Public Health"},{"key":"2025101814563271000_8.6.e021372.38","unstructured":"Heerkens Y , de Brouwer C , Engels J , et al . ICF manual unit 2: introduction to ICF linking rules and ICF core sets. In: Brouwer CPMde , Heerkens YF , Kant IJ , eds. Occupational health from a biopsychosocial perspective: an evidence based approach. mediview, 2015:1\u201324."},{"key":"2025101814563271000_8.6.e021372.39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.6999.251"},{"key":"2025101814563271000_8.6.e021372.40","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-021372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:56:46Z","timestamp":1760824606000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-021372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,15]]},"published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1136\/bmjopen-2017-021372"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-021372","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}